Florida

Effective October 1, 2021, any fee-for-service (FFS) claim submitted with a National Provider Identifier (NPI) for a provider not enrolled with Florida Medicaid will be denied, and the provider will not receive reimbursement for services. This includes claims that list a Referring, Ordering, Prescribing, or Attending (ROPA) provider. ROPA providers must be enrolled with Florida Medicaid following Title 42, Code of Federal Regulations, Section 455.410(b).  Starting October 1, 2021, claims will not be paid for any practitioner, group practice, facility, or pharmacy providing services to Florida Medicaid recipients based on a ROPA provider’s referral, order, prescription, or attending services, unless the ROPA provider identified by NPI on the FFS claim is actively enrolled with Florida Medicaid.

Florida Medicaid features a quick and easy, automated ROPA provider enrollment application on the Florida Medicaid Web Portal Enrollment Application Wizard page. Please visit the ROPA Provider Enrollment page of the Web Portal for updated information, including the recently created Unenrolled ROPA Provider List, ROPA Providers Frequently Asked Questions, and Quick Reference Guides on ROPA provider enrollment and claims billing.  Providers may call the Provider Services Contact Center at 1-800-289-7799, option 7, for billing assistance and option 4 for enrollment assistance.

Also in Florida, the Department of Business and Professional Regulation has proposed the below rules.

  • Proposed rule of the Department of Business and Professional Regulation would amend regulations under FAC 61N-1 regarding drug and device labeling requirements to revise the references to federal regulations incorporated by reference. Comments and hearing requests are due June 28, 2021.
  • Proposed rule of the Department of Business and Professional Regulation would amend regulations under FAC 61N-1 to update the application forms incorporated by reference for permits to be a diethyl ether manufacturer, distributor, dealer, or purchaser. Comments and hearing requests are due June 28, 2021.

For more information, contact NACDS’ Leigh Knotts at 803-243-7207.

2021-06-11T15:10:50-04:00June 11, 2021|Florida|

Florida

The Florida Board of Pharmacy issued a proposed rule that would amend regulations under FAC 64B16-31 to update references to the incorporated application forms for pharmacy interns, consultant pharmacists, nuclear pharmacists, and pharmacy technicians. Comments and hearing requests are due June 14, 2021.

For more information, contact NACDS’ Leigh Knotts at 803-243-7207.

2021-05-28T09:53:58-04:00May 28, 2021|Florida|

Florida

The Board of Pharmacy published a notice to amend regulations under FAC 64B16-31 to update the incorporated pharmacist licensure and pharmacy intern and technician registration forms.

Also in Florida, the Department of Health published a notice of a workshop to adopt regulations under FAC 64J-4 to establish requirements for the Prescription Drug Donation Repository Program. The workshop is scheduled for May 14, 2021, via video and teleconference.

For more information, contact NACDS’ Leigh Knotts at 803-408-9774.

2021-05-07T11:54:36-04:00May 7, 2021|Florida|

Florida

The Board of Pharmacy published a final rule to amend regulations under FAC 64B16-31 to update “smoking cessation” with “nicotine dependence” on the list of chronic health conditions for which a certified pharmacist may provide patient care services. The rule is effective April 29, 2021.

For more information, contact NACDS’ Leigh Knotts at 803-243-7207.

2021-04-23T12:26:49-04:00April 23, 2021|Florida|

Florida

Florida Medicaid will continue to align with the Medicare vaccine administration rates. These rates were updated by the Centers for Medicare and Medicaid Services effective March 15, 2021. COVID-19 vaccines administered with a date of service on or after March 15, 2021, must be paid at the new rates. All guidance applies to both the fee-for-service and Statewide Medicaid Managed Care delivery systems unless otherwise stated.

For more information, contact NACDS’ Leigh Knotts at 803-243-7207.

2021-04-16T10:03:26-04:00April 16, 2021|Florida|

Florida

The Department of Business and Professional Regulation issued a notice to announce its intentions to amend regulations under FAC 61N-1 regarding drug and device labeling requirements to make technical revisions to conform to statutes. The Department will be accepting comments but no due date has been specified.

Also in Florida,  the Department of Health issued an emergency rule to adopt regulations under FAC 64DER21-4 to require all health care practitioners and other enrolled COVID-19 vaccine providers to report to the online immunization information system within 24 hours the administration of any COVID-19 vaccine with an emergency use authorization from the FDA. The rule replaces a December 15 rule on the same topic. The rule is effective March 15 and expires June 13, 2021.

Lastly, in Florida, the Department of Health issued an emergency rule to adopt regulations under FAC 64DER21-5 to authorize redistribution of the COVID vaccine between vaccine providers within the state. The rule requires providers to receive approval from the Florida Vaccines for Children and Adults Program and requires tracking of vaccine redistribution between enrolled providers. The rule is a readoption of a December 21 emergency rule. The rule is effective March 17 and expires June 15, 2021.

For more information, contact NACDS’ Leigh Knotts at 803-243-7207.

2021-03-26T12:18:02-04:00March 26, 2021|Florida|

Florida

Under Executive Order 21-47, additional groups are now eligible to receive a COVID-19 vaccine. These groups are in addition to persons deemed to be extremely vulnerable to COVID-19, as determined by a physician. Such physician determination shall include a statement that the patient meets the defined eligibility criteria established by a form prescribed by the Florida Department of Health.

For more information, contact NACDS’ Leigh Knotts at 803-243-7207.

2021-03-19T14:28:51-04:00March 19, 2021|Florida|

Florida

The Board of Pharmacy issued a proposed rule to amend regulations under FAC 64B16-31 to clarify the list of chronic health conditions for which a pharmacist can provide to patients of a collaborating physician pursuant to a pending Collaborative Pharmacy Practice Agreement. Comments and hearing requests are due March 8, 2021.

For more information, contact NACDS’ Leigh Knotts at 803-243-7207.

2021-02-19T11:04:43-05:00February 19, 2021|Florida|

Florida

The Board of Pharmacy announced a notice of intention to amend regulations under FAC 64B16-31 to clarify the meaning of a chronic health condition. Comment due date is not specified.

Also in Florida. The Department of Business and Professional Regulation, Division of Drugs, Devices, and Cosmetics, announced the following notices:

  • Notice to amend regulations under 61N-2 to adopt regulations concerning the application for registration as an international exporter of prescription drugs. Comment due date is not specified.
  • Notice to amend regulations under 61N-1 to adopt regulations concerning the international importation of prescription drugs. Comment due date is not specified.
  • Notice to amend regulations under 61N-2 to adopt regulations concerning the application for registration as an international importer of prescription drugs. Comment due date is not specified.
  • Notice to amend regulations under 61N-2 to adopt regulations concerning the application for registration as an international prescription drug wholesale distributor. Comment due date is not specified.

For more information, contact NACDS’ Leigh Knotts at 803-243-7207.

2021-02-05T08:25:07-05:00February 5, 2021|Florida|
Go to Top